Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Michele Freesmeier"'
Autor:
Mohammed Milhem, Yousef Zakharia, Jayanshu Jain, Melanie Frees, Hesham Yasin, Jaime Bonner, Michele Freesmeier, Rohan Garje, Vyshak Alva Venur
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/702f0761c1b842639ed3cdce5eb7cb53
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::356b3abc355cb7481a8e693d8e774660
https://doi.org/10.1136/jitc-2022-sitc2022.1265
https://doi.org/10.1136/jitc-2022-sitc2022.1265
Autor:
Aaron D. Bossler, Weizhou Zhang, Michele Freesmeier, Yousef Zakharia, Varun Monga, Umang Swami, Mohammed M. Milhem
Publikováno v:
Melanoma Res
Pembrolizumab is an effective therapy for patients with metastatic melanoma. However, not all patients derive benefit. It is postulated that an increase in regulatory T cells in melanoma patients can impair the response to immunotherapies. Continuous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a6060837904eb5103260bd143e9041b
https://doi.org/10.1097/cmr.0000000000000592
https://doi.org/10.1097/cmr.0000000000000592
Autor:
Michael D. Henry, Rithu Srikantha, Umang Swami, Yousef Zakharia, Marion Vanneste, Michele Freesmeier, Melanie Frees, Noah Frydenlund, Mirza Khan, Mohammed M. Milhem, Varun Monga, Aaron D. Bossler
Publikováno v:
Oncotarget
// Yousef Zakharia 1 , Varun Monga 1 , Umang Swami 1 , Aaron D. Bossler 4 , Michele Freesmeier 1 , Melanie Frees 1 , Mirza Khan 5 , Noah Frydenlund 2 , Rithu Srikantha 2 , Marion Vanneste 3 , Michael Henry 3 and Mohammed Milhem 1 1 Department of Hema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e0c4f67a666fdefa1e20f94f60e22f0
https://doi.org/10.18632/oncotarget.21269
https://doi.org/10.18632/oncotarget.21269
Autor:
Hesham Yasin, Melanie Frees, Jaime Bonner, Mohammed M. Milhem, Vyshak Alva Venur, Rohan Garje, Jayanshu Jain, Yousef Zakharia, Michele Freesmeier
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background In the United States, melanoma is the fifth leading cancer in men and the seventh in women. Immunotherapy has improved antitumor activity and survival. Overall response rate (ORR) with single agent PD-1 inhibitor is 35%, and 55% with the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0300aaf6a5419ab822029625376fd138
https://doaj.org/article/702f0761c1b842639ed3cdce5eb7cb53
https://doaj.org/article/702f0761c1b842639ed3cdce5eb7cb53
Autor:
Michael J. Goodheart, Jean Hansen, Anna M. Button, Jean-Marie Stephan, David Bender, Michele Freesmeier
Publikováno v:
Gynecologic oncology. 138(1)
Objective Many clinicians limit chemotherapy doses based on a maximum body surface area (BSA) of 2m 2 . We sought to determine how chemotherapy-related toxicities compared between groups of patients that varied with respect to BSA. We hypothesized th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29ef146f584ef45392bc352c392de9be
https://pubmed.ncbi.nlm.nih.gov/25958318
https://pubmed.ncbi.nlm.nih.gov/25958318
Autor:
Jean-Marie Stephan, Anna M. Button, David Bender, Michael J. Goodheart, Jean M. Hansen, Michele Freesmeier
Publikováno v:
Gynecologic Oncology. 133:165-166
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::adea93aa0e10ede4cb2bed2236b2bc4b
https://doi.org/10.1016/j.ygyno.2014.03.437
https://doi.org/10.1016/j.ygyno.2014.03.437
Autor:
Michele Freesmeier, Anna M. Button, Jean-Marie Stephan, Jean Hansen, Michael J. Goodheart, David Bender
Publikováno v:
Gynecologic Oncology. 134:433
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb048f3d8f75f953a55c7eb47545951a
https://doi.org/10.1016/j.ygyno.2014.04.027
https://doi.org/10.1016/j.ygyno.2014.04.027